Cell Press Reviews: Stem Cells to Model and Treat Disease provides in-depth and up-to-date reviews on the myriad ways that stem cells are being used to better understand and treat human disease. This publication offers essays from leaders in the stem cell field on some of the most important questions being faced in clinics and research labs, including the safety and efficacy of stem cell treatments, the use of stem cells to regenerate organs, the use of reprogrammed stem cells to model and treat disease, and the use of stem cells in clinical applications such as HIV disease and stroke. Contributors to this compilation include many prominent researchers in the field, such as:
* Shinya Yamanaka, recipient, 2012 Nobel Prize in Physiology or Medicine; Professor, Center for iPS Cell Research and Application, Kyoto University and Gladstone Institute of Cardiovascular Disease, San Francisco, CA; President, International Society for Stem Cell Research
* George Q. Daley, Director, Stem Cell Transplantation Program at Children's Hospital Boston; Professor, Children's Hospital Boston and Harvard Medical School
* Irving Weissman, Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Cell Press Reviews: Stem Cells to Model and Treat Disease offers accessible and timely insights into the future promise and existing challenges of stem cell research.
This publication is part of the Cell Press Reviews series, which brings together topical review articles recently published in Cell Press journals, including the Trends in... series. These compilations are curated by Cell Press journal editors and offer comprehensive updates from leaders in the field on the most cutting-edge and important scientific questions.

1) Stem cell therapies could change medicine... if they get the chance; Irving Weissman; Cell Stem Cell 2) Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders? Olle Lindvall; Cell Stem Cell 3) Assessing the safety of stem cell therapeutics; Chris E.P. Goldring, Paul A. Duffy, Nissim Benvenisty, Peter W. Andrews, Uri Ben-David, Rowena Eakins, Neil French, Neil A. Hanley, Lorna Kelly, Neil R. Kitteringham, Jens Kurth, Deborah Ladenheim, Hugh Laverty, James McBlane, Gopalan Narayanan, Sara Patel, Jens Reinhardt, Annamaria Rossi, Michaela Sharpe and B. Kevin Park; Cell Stem Cell 4) The promise and perils of stem cell therapeutics; George Q. Daley; Cell Stem Cell 5) Reprogramming cellular identity for regenerative medicine; Anne B.C. Cherry and George Q. Daley; Cell 6) Cardiac stem cell therapy and the promise of heart regeneration; Jessica C. Garbern and Richard T. Lee; Cell Stem Cell 7) Next-generation regenerative medicine: Organogenesis from stem cells in 3D culture; Yoshiki Sasai; Cell Stem Cell 8) Induced pluripotent stem cells: past, present, and future; Shinya Yamanaka; Cell Stem Cell 9) Remodeling neurodegeneration: Somatic cell reprogramming-based models of adult neurological disorders; Liang Qiang, Ryousuke Fujita and Asa Abeliovich; Neuron 10) Therapeutic translation of iPSCs for treating neurological disease; Diana X. Yu, Maria C. Marchetto and Fred H. Gage; Cell Stem Cell 11) Modeling human disease with pluripotent stem cells: From genome association to function; Florian T. Merkle and Kevin Eggan; Cell Stem Cell 12) How can human pluripotent stem cells help decipher and cure Huntington's disease? Anselme Perrier and Marc Peschanski; Cell Stem Cell 13) Integrating human pluripotent stem cells into drug development; Sandra J. Engle and Dinesh Puppala; Cell Stem Cell 14) Process engineering of human pluripotent stem cells for clinical application; Margarida Serra, Catarina Brito, Cláudia Correia and Paula M. Alves; Trends in Biotechnology 15) Mesenchymal stem cells: Therapeutic outlook for stroke; Osamu Honmou, Rie Onodera, Masanori Sasaki, Stephen G. Waxman and Jeffery D. Kocsis; Trends in Molecular Medicine 16) The potential of stem cells as an in vitro source of red blood cells for transfusion; Anna Rita Migliaccio, Carolyn Whitsett, Thalia Papayannopoulou and Michel Sadelain; Cell Stem Cell 17) Hematopoietic-stem-cell-based gene therapy for HIV disease; Hans-Peter Kiem, Keith R. Jerome, Steven G. Deeks and Joseph M. McCune; Cell Stem Cell 18) Stem cells in translation; Cell

Surveillance and Threat Detection offers readers a complete understanding of the terrorist/criminal cycle, and how to interrupt that cycle to prevent an attack.

Terrorists and criminals often rely on pre-attack and pre-operational planning and surveillance activities that can last a period of weeks, months, or even years. Identifying and disrupting this surveillance is key to prevention of attacks. The systematic capture of suspicious events and the correlation of those events can reveal terrorist or criminal surveillance, allowing security professionals to employ appropriate countermeasures and identify the steps needed to apprehend the perpetrators. The results will dramatically increase the probability of prevention while streamlining protection assets and costs.

Readers of Surveillance and Threat Detection will draw from real-world case studies that apply to their real-world security responsibilities. Ultimately, readers will come away with an understanding of how surveillance detection at a high-value, fixed site facility can be integrated into an overall security footprint for any organization.